H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 13.2% of adults in Jacksonville have diagnosed diabetes — 1.2 points above the U.S. 12% figure. Census population 985,843. Florida Medicare wound biologics: First Coast Service Options (JN). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Jacksonville clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Jacksonville storefront.
Build Your Biologic Treatment Center in Jacksonville, FL for clinics & physicians. Start or expand your bi… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of biologic treatment center in Jacksonville: (1) CDC PLACES (2023, crude) estimates 13.2% of adults in Jacksonville have diagnosed diabetes — 1.2 points above the U.S. 12% figure. (2) Florida Part B wound biologics are reviewed by First Coast Service Options under JN, shared with no other states. We help with the second file. We do not pretend to be a Jacksonville storefront.
National Build Your Biologic Treatment Center notes (how the product actually works)13.9% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 500k–1M with 985,843 residents will still mix those payers. CDC PLACES (2023, crude) estimates 13.2% of adults in Jacksonville have diagnosed diabetes — 1.2 points above the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Jacksonville trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 13.2% of adults in Jacksonville have diagnosed diabetes — 1.2 points above the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 13.2% of adults — 1.2 points above the U.S. 12% figure. Obesity is 34.8%; arthritis is 25.4%. That is place-level BRFSS modeling, not a clinic census and not a Jacksonville trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Florida.
No. They are B2B distribution pages for licensed providers. Patients in Jacksonville should speak with their clinician, not use a distributor URL as care instructions.
Regulatory lane, storage, and JN coding. Amniotic products used as 361 HCT/Ps are not “better gauze.” Match wound stage and coverage article before you convert the cart.
Bring specialty, monthly joint / regenerative volume, and whether you bill JN FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 13.2% diabetes and 25.4% arthritis for Jacksonville — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Jacksonville, FL.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Jacksonville is JN geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Jacksonville — 1.2 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Florida Part B wound biologics follow this contractor (siblings: no other states). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Jacksonville. Useful for joint-program math; still needs a diagnosis and privileging.
No Jacksonville storefront. Joe Bradley is an active practice owner. biologic treatment center stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.